Robert Paul Carlile
Known title: DirectorCIK: 0001695923
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Expeditors International Hits New High Amid Sector News. Expeditors International (EXPD) recently reached a fresh high, prompting questions about whether the stock has further upside potential. The company was also highlighted in a Zacks.com feature alongside other major firms. While the stock is trading near the top of its 52-week range, the average analyst target price remains below the current market level, reflecting mixed views on its valuation.
Transaction History
| MVIS | ▲ Buy | Option Exercise | 4,670 | $0 | 9/1/2026 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 22,007 | $0 | 6/5/2026 | View on chart |
| EXPD | ▲ Buy | Grant | 1,306 | $0 | 5/5/2026 | View on chart |
| MVIS | ▲ Buy | Grant | 187,900 | $100K | 3/15/2026 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 22,007 | $0 | 3/2/2026 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 22,007 | $0 | 12/1/2025 | View on chart |
| EXPD | ▼ Sell | Open Market | 2,500 | $301K | 9/5/2025 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 22,007 | $0 | 9/2/2025 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 20,112 | $0 | 6/5/2025 | View on chart |
| EXPD | ▲ Buy | Grant | 1,883 | $0 | 5/6/2025 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 20,112 | $0 | 3/3/2025 | View on chart |
| EXPD | ▼ Sell | Open Market | 3,000 | $363K | 12/10/2024 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 20,113 | $0 | 12/2/2024 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 20,113 | $0 | 9/3/2024 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 11,439 | $0 | 5/17/2024 | View on chart |
| EXPD | ▲ Buy | Grant | 1,740 | $0 | 5/7/2024 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 11,439 | $0 | 3/1/2024 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 11,439 | $0 | 12/1/2023 | View on chart |
| MVIS | ▲ Buy | Grant | 5,076 | $10K | 11/13/2023 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 11,439 | $0 | 9/1/2023 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 7,492 | $0 | 5/16/2023 | View on chart |
| EXPD | ▲ Buy | Grant | 1,766 | $0 | 5/2/2023 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 7,492 | $0 | 3/1/2023 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 7,492 | $0 | 12/1/2022 | View on chart |
| MVIS | ▲ Buy | Option Exercise | 7,492 | $0 | 9/1/2022 | View on chart |
| EXPD | ▲ Buy | Grant | 1,948 | $0 | 5/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
MicroVision stock falls after reaffirming 2026 revenue outlook
MicroVision shares declined after the company reaffirmed its 2026 revenue outlook and outlined its path to profitability. Despite these updates on commercial growth, the stock dropped in trading. The share price is currently near its 52-week low, reflecting the market's reaction to the reiterated guidance.
MicroVision stock falls after reaffirming 2026 revenue outlook. MicroVision shares declined after the company reaffirmed its 2026 revenue outlook and outlined its path to profitability. Despite these updates on commercial growth, the stock dropped in trading. The share price is currently near its 52-week low, reflecting the market's reaction to the reiterated guidance.